Found 28 matching trials
Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale PHASE2 This study aims at exploring the use of Dapagliflozin and Empagliflozin in ...
Show More Location
Centre Hospitalier Universitaire Vaudois (CHUV)
Learn More & Join Trial
Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects PHASE4 New strategies trying to achieve blood pressure control and consequently re...
Show More Location
University of Campinas (UNICAMP)
Learn More & Join Trial
The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM PHASE3 This study will enroll eligible subjects into a long-term safety study (Par...
Show More Learn More & Join Trial
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients PHASE3 This study is being carried out to see if dapagliflozin in addition to glim...
Show More Learn More & Join Trial
Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus N/A Research objectives:
The aim of the study to check the effect of Dapaglifl...
Show More Location
Tanta University Hospital
Learn More & Join Trial
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study PHASE1 To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, ...
Show More Location
Chung-Ang University Gwangmyeong Hospital
Learn More & Join Trial
Effect of Sodium-glucose Cotransporter-2 Inhibitors (SGLT-2i) on Proteinuria in Nephrotic Children Older Than 10 Years PHASE4 The goal of this clinical trial is to evaluate the effect of ACE inhibitors...
Show More Location
Mansoura University Children's Hospital
Learn More & Join Trial
Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants PHASE1 The purpose of this study is to evaluate whether the pharmacokinetics (body...
Show More Location
Icon Clinical Pharmacology
Learn More & Join Trial
Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin. PHASE4 Japanese male and female patients with Type 2 Diabetes and aged ≥ 20 years ...
Show More Learn More & Join Trial
Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus PHASE4 The Investigator hypothesize that Dapagliflozin will improve EPC number and...
Show More Location
The GW Medical Faculty Associates
Learn More & Join Trial